Author Archives: Thomas Payne

TScan Therapeutics Named the Highest-Placed Midsize Biotechnology Company in The Top Places to Work for 2022 by The Boston Globe

By

TScan Therapeutics to Participate in the 5th Annual Evercore ISI HealthCONx Conference

By

TScan Therapeutics Presents Preclinical Data for Solid Tumor Program at the 37th Society for Immunotherapy of Cancer Annual Meeting

By

TScan Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update

By

TScan Therapeutics Announces Upcoming Virtual Investor Event

By

TScan Therapeutics Announces Upcoming Poster Presentation at the 64th American Society of Hematology Annual Meeting and Exposition

By

TScan Therapeutics Announces Upcoming Poster Presentations at the 37th Society for Immunotherapy of Cancer Annual Meeting

By

TScan Therapeutics to Participate in Upcoming Investor Conferences

By

TScan Therapeutics Secures Convertible Debt Facility for up to $60 Million with K2 HealthVentures

By

TScan Therapeutics to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference

By